Angiotensin I converting enzyme activity in adriamycin induced nephrosis in rats
β Scribed by N. Venkatesan; C.V. Ramesh; R. Jayakumar; Gowri Chandrakasan
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 751 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0300-483X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Angiotensin II has previously been reported to have in vivo and in vitro cardiac hypertrophic effects. We used the salt-sensitive Dahl rat genetic strain to separate mechanical (pressure overload) vs. hormonal (renin-angiotensin system) input in cardiac hypertrophy. Blood pressure was significantly
Our objective was to measure serum angiotensin-converting enzyme (ACE) activity in patients with onchocerciasis. Serum ACE activity is commonly used in the diagnosis and follow-up of patients with sarcoidosis. However, serum ACE activity can also be elevated in a number of other granulomatous disord
## Abstract Captopril and enalaprilβangiotensinβconverting enzyme (ACE) inhibitorsβwere evaluated for their antioxidative protective action against adriamycinβinduced cardiac and hepatic toxicity. Rats were treated with either captopril (10 mg kg^β1^) or enalapril (2 mg kg^β1^) intragastrically (i.